Behavior; DNA methylation; Developmental programming; E3; Epigenetics; Estriol; Pregnancy; Reproduction; Estrogens; Receptors, Estrogen; Steroids; Animals; Brain/metabolism; Epigenesis, Genetic; Female; Fetus/metabolism; Male; Mice; Estrogens/genetics; Estrogens/metabolism; Receptors, Estrogen/genetics; Receptors, Estrogen/metabolism; Brain; Fetus; Biotechnology; Structural Biology; Ecology, Evolution, Behavior and Systematics; Physiology; Biochemistry, Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all); Plant Science; Developmental Biology; Cell Biology; General Agricultural and Biological Sciences; General Biochemistry, Genetics and Molecular Biology
Résumé :
[en] BACKGROUND: Estriol (E3) is a steroid hormone formed only during pregnancy in primates including humans. Although E3 is synthesized at large amounts through a complex pathway involving the fetus and placenta, it is not required for the maintenance of pregnancy and has classically been considered virtually inactive due to associated very weak canonical estrogen signaling. However, estrogen exposure during pregnancy may have an effect on organs both within and outside the reproductive system, and compounds with binding affinity for estrogen receptors weaker than E3 have been found to impact reproductive organs and the brain. Here, we explore potential effects of E3 on fetal development using mouse as a model system.
RESULTS: We administered E3 to pregnant mice, exposing the fetus to E3. Adult females exposed to E3 in utero (E3-mice) had increased fertility and superior pregnancy outcomes. Female and male E3-mice showed decreased anxiety and increased exploratory behavior. The expression levels and DNA methylation patterns of multiple genes in the uteri and brains of E3-mice were distinct from controls. E3 promoted complexing of estrogen receptors with several DNA/histone modifiers and their binding to target genes. E3 functions by driving epigenetic change, mediated through epigenetic modifier interactions with estrogen receptors rather than through canonical nuclear transcriptional activation.
CONCLUSIONS: We identify an unexpected functional role for E3 in fetal reproductive system and brain. We further identify a novel mechanism of estrogen action, through recruitment of epigenetic modifiers to estrogen receptors and their target genes, which is not correlated with the traditional view of estrogen potency.
Disciplines :
Médecine de la reproduction (Gynécologie, andrologie, obstétrique)
Auteur, co-auteur :
Zhou, Yuping; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA
Gu, Baoxia; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA ; Present Address: Reproductive Medicine Center of Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China, 450003
Brichant, Géraldine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR) ; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA
Singh, Jay Prakash; Department of Comparative Medicine and of Cellular and Molecular Physiology, Yale University, New Haven, CT, 06520, USA
Yang, Huan; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA
Chang, Hao; Department of Genetics, Yale University, New Haven, CT, 06520, USA
Zhao, Yanding; Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA
Cheng, Chao; Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA
Liu, Zhong-Wu; Present Address: Reproductive Medicine Center of Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China, 450003
Alderman, Myles H; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA ; Department of Genetics, Yale University, New Haven, CT, 06520, USA ; Present Address: Yale Stem Cell Center, Yale University, New Haven, CT, 06520, USA
Lu, Lingeng; Department of Chronic Disease Epidemiology, Yale University, New Haven, CT, 06520, USA
Yang, Xiaoyong; Department of Comparative Medicine and of Cellular and Molecular Physiology, Yale University, New Haven, CT, 06520, USA
Gao, Xiao-Bing; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA ; Department of Comparative Medicine and of Cellular and Molecular Physiology, Yale University, New Haven, CT, 06520, USA
Taylor, Hugh S ; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06520, USA. hugh.taylor@yale.edu
Head KA. Estriol: safety and efficacy. Altern Med Rev. 1998;3(2):101–13.
Longcope C. Estriol production and metabolism in normal women. J Steroid Biochem. 1984;20(4B):959–62. DOI: 10.1016/0022-4731(84)90004-9
Flood C, Pratt JH, Longcope C. The metabolic clearance and blood production rates of estriol in normal, non-pregnant women. J Clin Endocrinol Metab. 1976;42(1):1–8. DOI: 10.1210/jcem-42-1-1
Kuijper EA, Ket JC, Caanen MR, Lambalk CB. Reproductive hormone concentrations in pregnancy and neonates: a systematic review. Reprod Biomed Online. 2013;27(1):33–63. DOI: 10.1016/j.rbmo.2013.03.009
Mesiano S. Chapter 11 - Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development. Editor(s): Jerome F. Strauss, Robert L. Barbieri, Yen and Jaffe's Reproductive Endocrinology (Eighth Edition), Elsevier. 2019:256-284.e9, ISBN 9780323479127. 10.1016/B978-0-323-47912-7.00011-1.
Albrecht ED, Pepe GJ. Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy. Int J Dev Biol. 2010;54(2-3):397–408. DOI: 10.1387/ijdb.082758ea
Laredo SA, Villalon Landeros R, Trainor BC. Rapid effects of estrogens on behavior: environmental modulation and molecular mechanisms. Front Neuroendocrinol. 2014;35(4):447–58. DOI: 10.1016/j.yfrne.2014.03.005
Rich RL, Hoth LR, Geoghegan KF, Brown TA, LeMotte PK, Simons SP, et al. Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci U S A. 2002;99(13):8562–7. DOI: 10.1073/pnas.142288199
Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8–30. DOI: 10.1016/j.yfrne.2013.08.001
Hong H, Branham WS, Ng HW, Moland CL, Dial SL, Fang H, et al. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and alpha-fetoprotein. Toxicol Sci. 2015;143(2):333–48. DOI: 10.1093/toxsci/kfu231
Bromer JG, Wu J, Zhou Y, Taylor HS. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology. 2009;150(7):3376–82. DOI: 10.1210/en.2009-0071
Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J. 2010;24(7):2273–80. DOI: 10.1096/fj.09-140533
Akbas GE, Song J, Taylor HS. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol. 2004;340(5):1013–23. DOI: 10.1016/j.jmb.2004.05.052
Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm Cancer. 2010;1(3):146–55. DOI: 10.1007/s12672-010-0015-9
Shi JF, Li XJ, Si XX, Li AD, Ding HJ, Han X, et al. ERalpha positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells. Biochem Biophys Res Commun. 2012;427(1):47–53. DOI: 10.1016/j.bbrc.2012.08.144
Cui M, Wen Z, Yang Z, Chen J, Wang F. Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells. Mol Biol Rep. 2009;36(8):2201–7. DOI: 10.1007/s11033-008-9435-9
Russell JK, Jones CK, Newhouse PA. The role of estrogen in brain and cognitive aging. Neurotherapeutics. 2019;16(3):649–65. DOI: 10.1007/s13311-019-00766-9
Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, Cristofani R, et al. The role of sex and sex hormones in neurodegenerative diseases. Endocr Rev. 2020;41(2):273-319.
Santagati S, Melcangi RC, Celotti F, Martini L, Maggi A. Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem. 1994;63(6):2058–64. DOI: 10.1046/j.1471-4159.1994.63062058.x
Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol. 2001;64(3):251–67. DOI: 10.1016/S0301-0082(00)00059-9
Wang S, Che T, Levit A, Shoichet BK, Wacker D, Roth BL. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature. 2018;555(7695):269–73. DOI: 10.1038/nature25758
Perkins MS, Louw-du Toit R, Africander D. A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-alpha and -beta. J Steroid Biochem Mol Biol. 2017;174:27–39. DOI: 10.1016/j.jsbmb.2017.07.022
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138(3):863–70. DOI: 10.1210/endo.138.3.4979
Sasson S, Notides AC. The estriol-induced inhibition of the estrogen receptor's positive cooperativity. J Steroid Biochem. 1984;20(4B):1021–6. DOI: 10.1016/0022-4731(84)90013-X
Kaneko K, Choudhuri S. Chapter 52 - epigenetics in reproduction and development. In: Gupta RC, editor. Reproductive and Developmental Toxicology. 2nd ed: Academic Press; 2017. p. 1005–21. 10.1016/B978-0-12-804239-7.00052-4
Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril. 2007;87(1):24–32. DOI: 10.1016/j.fertnstert.2006.05.077
Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, et al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science. 2008;319(5860):202–6. DOI: 10.1126/science.1147674
Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005;19(6):857–64. DOI: 10.1016/j.molcel.2005.08.027
Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet. 2009;41(1):125–9. DOI: 10.1038/ng.268
Frick KM. Molecular mechanisms underlying the memory-enhancing effects of estradiol. Horm Behav. 2015;74:4–18. DOI: 10.1016/j.yhbeh.2015.05.001
Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005;19(8):1951–9. DOI: 10.1210/me.2004-0390
Vasudevan N, Pfaff DW. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front Neuroendocrinol. 2008;29(2):238–57. DOI: 10.1016/j.yfrne.2007.08.003
Nayak V, Xu C, Min J. Composition, recruitment and regulation of the PRC2 complex. Nucleus. 2011;2(4):277–82. DOI: 10.4161/nucl.2.4.16266
Smith CC, Taylor HS. Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J. 2007;21(1):239–46. DOI: 10.1096/fj.06-6635com
Jorgensen EM, Alderman MH 3rd, Taylor HS. Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure. FASEB J. 2016;30(9):3194–201. DOI: 10.1096/fj.201500089R
Bruning JB, Parent AA, Gil G, Zhao M, Nowak J, Pace MC, et al. Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol. 2010;6(11):837–43. DOI: 10.1038/nchembio.451
Mueller SO, Hall JM, Swope DL, Pedersen LC, Korach KS. Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta. J Biol Chem. 2003;278(14):12255–62. DOI: 10.1074/jbc.M203578200
Hansen JC, Gorski J. Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature. J Biol Chem. 1986;261(30):13990–6. DOI: 10.1016/S0021-9258(18)66970-4
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95(7):927–37. DOI: 10.1016/S0092-8674(00)81717-1
Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci U S A. 1999;96(7):3999–4004. DOI: 10.1073/pnas.96.7.3999
Wu YL, Yang X, Ren Z, McDonnell DP, Norris JD, Willson TM, et al. Structural basis for an unexpected mode of SERM-mediated ER antagonism. Mol Cell. 2005;18(4):413–24. DOI: 10.1016/j.molcel.2005.04.014
Lupien M, Jeyakumar M, Hebert E, Hilmi K, Cotnoir-White D, Loch C, et al. Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12. Mol Endocrinol. 2007;21(4):797–816. DOI: 10.1210/me.2006-0074
Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J. The many faces of estrogen signaling. Biochem Med (Zagreb). 2014;24(3):329–42. DOI: 10.11613/BM.2014.035
Liu ZW, Faraguna U, Cirelli C, Tononi G, Gao XB. Direct evidence for wake-related increases and sleep-related decreases in synaptic strength in rodent cortex. J Neurosci. 2010;30(25):8671–5. DOI: 10.1523/JNEUROSCI.1409-10.2010
Arrant AE, Schramm-Sapyta NL, Kuhn CM. Use of the light/dark test for anxiety in adult and adolescent male rats. Behav Brain Res. 2013;256:119–27. DOI: 10.1016/j.bbr.2013.05.035
Takao K, Miyakawa T. Light/dark transition test for mice. J Vis Exp. 2006;1:104.
Lueptow LM. Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. J Vis Exp. 2017;126:55718.
Bromley-Brits K, Deng Y, Song W. Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. J Vis Exp. 2011;53:2920.
Liu ZW, Gao XB. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J Neurophysiol. 2007;97(1):837–48. DOI: 10.1152/jn.00873.2006
Liu ZW, Gan G, Suyama S, Gao XB. Intracellular energy status regulates activity in hypocretin/orexin neurones: a link between energy and behavioural states. J Physiol. 2011;589(17):4157–66. DOI: 10.1113/jphysiol.2011.212514
Ruan HB, Han X, Li MD, Singh JP, Qian K, Azarhoush S, et al. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability. Cell Metab. 2012;16(2):226–37. DOI: 10.1016/j.cmet.2012.07.006
